Ignite Creation Date:
2024-06-16 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06448936
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-07
First Post:
2024-06-04
Brief Title:
Quality of Life in Patients With Difficult-to-treat Basal Cell Carcinoma
Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Organization:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Study Overview
Official Title:
Quality of Life Assessment in Patients Undergoing Surgery for Difficult-to-treat Basal Cell Carcinoma of the Face in Stage IIA or IIIB According to the Classification of the European Association of Dermato Oncology
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
FACE-QOL
Brief Summary:
FACE-QoL is an observational prospective multicenter study to evaluate the impact of surgical treatment on Quality of Life in patients with stage IIA and IIIB difficult-to-treat basal cell carcinoma of the face according to the European Academy of Dermato Oncology classification using Patient Reported Outcomes
The main questions it aims to answer are
Surgery as a gold standard for treatment can lead to an improvement in patients quality of life in difficult-to-treat basal cell carcinoma in functionally and cosmetically challenging sites of the face ie stage IIA and IIIB
Identify which clinical and individual variables have the greatest impact on patients quality of life
Participants will answer questionnaires about quality of life and the impact of the disease on their lives
The main questions it aims to answer are
Surgery as a gold standard for treatment can lead to an improvement in patients quality of life in difficult-to-treat basal cell carcinoma in functionally and cosmetically challenging sites of the face ie stage IIA and IIIB
Identify which clinical and individual variables have the greatest impact on patients quality of life
Participants will answer questionnaires about quality of life and the impact of the disease on their lives
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None